Navigation Links
2 BUSM faculty receive Alzheimer's disease grants
Date:7/11/2013

(Boston) - David Harris, MD, PhD, chair and professor of biochemistry and Benjamin Wolozin, MD, PhD, professor of pharmacology and experimental therapeutics and neurology at Boston University School of Medicine (BUSM), have received Massachusetts Neuroscience Consortium (MNC) Awards. Each will receive a $250,000 grant allowing their teams to explore new therapeutic targets for Alzheimer's disease.

Harris is developing a novel approach to the therapy of Alzheimer's disease based on targeting a newly recognized molecular pathway responsible for neurodegeneration. Based on this approach, drug compounds have the potential to overcome some of the limitations of existing medications. Current treatments are largely ineffective and do not halt the cognitive decline associated with the disease.

"This award will significantly enhance our ability to develop improved therapies for Alzheimer's disease by allowing us to interact with industry partners, which is an important element of drug development," said Harris.

Harris' laboratory at BUSM investigates the molecular and cellular mechanisms underlying two classes of human neurodegenerative disorders: prion diseases and Alzheimer's disease. Prion and Alzheimer's diseases are part of a larger group of neurodegenerative disorders, including Parkinson's, Huntington's and several other diseases.

Wolozin is developing compounds that inhibit aggregation and toxicity caused by TDP-43, a protein that forms aggregates in Alzheimer's disease as well as other diseases, such as amyotrophic lateral sclerosis and frontotemporal dementia. He is known for his Alzheimer's research, which focuses on the role of cholesterol in Alzheimer's disease and investigating mechanisms in which statins may impact the pathophysiology of the disease.

"This grant emphasizes the importance of collaboration between BUSM and development programs at major pharmaceutical companies in the Boston area," said Wolozin.

Principal Investigator of the project, Wolozin is working with Marcie Glicksman, PhD, and Kevin Hodgetts, PhD, co-directors of the Laboratory for Drug Discovery in Neurodegeneration (LDDN) at Brigham and Women's Hospital. The teams will divide the work between biology and chemistry.


'/>"/>

Contact: Gina Orlando
gina.orlando@bmc.org
617-638-8490
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Faculty of 1000 announces partnership between F1000Prime and docwise
2. Creighton University Welcomes New Faculty Member to Master of Public Health Program
3. Faculty List for Continuing Medical Education (CME) Conference 17th Annual Conference on Hypertension, Diabetes and Dyslipidemia Released by Continuing Education Company
4. 8th edition of LSUHSC facultys textbook published
5. Concordia University, Nebraska Faculty Member Headed to Guatemala for Mission Trip
6. Renowned medical genetics pioneer to join LA BioMed faculty
7. MCG faculty member, former hostage returns to Kuwait as Fulbright Scholar
8. Radiation Research Society honors 2 faculty
9. RIT receives $3.2 million award from the NSF to advance female faculty
10. Faculty from UCLA Center for Autism Research and Treatment receive multiple NIH awards
11. College biology faculty named Leadership Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... February 19, 2017 , ... ... healthcare, will join forces with Healthwise ® at HIMSS 2017 ... industry leader in evidence-based health education, technology and services, will demonstrate a voice-powered ...
(Date:2/18/2017)... ... 17, 2017 , ... CONTACT:, Glenn Vallecillos, MD, FACS, +1 ... Dr. Glenn Vallecillos experiments SculpSure, the hot, new, aesthetic, non-surgical procedure ... been centered around that idea that to achieve ones desired results a surgical ...
(Date:2/17/2017)... ... February 17, 2017 , ... Smiles by Seese is ... in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and highly ... one roof. Smiles by Seese serves patients of all ages with excellence in general, ...
(Date:2/17/2017)... ... 2017 , ... For the first time, International Scholarship and ... floor for the 2017 HIMSS Conference & Exhibition at the Orange ... than 40,000 healthcare industry professionals are expected at the conference, where they will ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... named a finalist in the 8th Annual DecisionHealth Platinum Awards in recognition of ... Qualis Health’s work is recognized across multiple award categories, highlighting four of the ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... -- Summary Provides understanding and access to the ... healthcare companies. ... The Global Allergy Partnering Terms and Agreements since 2010 report ... by the world,s leading healthcare companies. - Trends ... Deals listed by company A-Z, industry sector, stage of development, technology ...
(Date:2/16/2017)... and SCOTTSDALE, Ariz. , Feb. 16, ... Health Information Exchange (HIE), announced today it is partnering with ... HealthInfoNet,s HIE contains 98% of all Maine ... Maine hospitals and over 500 ambulatory care ... Directors, HealthInfoNet plans to deploy Orion Health,s Amadeus , ...
(Date:2/16/2017)... 2017   Spectralink Corporation , the global ... retail, manufacturing and hospitality industries, today announced the ... symbology support features of its PIVOT™:SC (8744) ... The study, conducted by The Tolly Group, showed ... phones with dedicated hardware scanners. Spectralink ...
Breaking Medicine Technology: